METASTATIC HEPATOCELLULAR CARCINOMA

Clinical trials for METASTATIC HEPATOCELLULAR CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC HEPATOCELLULAR CARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 12 Not yet recruiting 1 Not yet finished but already full! 5 Completed 1 Terminated 1

New drug duo aims to control advanced liver cancer

Disease control Completed

This study tested a combination of two drugs, futibatinib and pembrolizumab, for people with advanced liver cancer that had spread and stopped responding to initial treatment. The goal was to see if the combination could help control the cancer's growth and extend the time before…

Matched conditions: METASTATIC HEPATOCELLULAR CARCINOMA

Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

METASTATIC HEPATOCELLULAR CARCINOMA

Get alerted when new METASTATIC HEPATOCELLULAR CARCINOMA trials appear

New drug duo aims to control advanced liver cancer